Stockscreener 앱 받기
100.34
2.23%
2.19
시간 외 거래:
100.98
0.64
+0.64%
Illumina Inc 주식(ILMN)의 최신 뉴스
Infinity Bio Secures $8M Series A and Acquires Serimmune to Dominate Antibody Reactome Market - Stock Titan
DNA/Gene Microarray Market Future Trends and Scope Analysis - openPR.com
How the DNA Data Storage Market Will Evolve by 2032Growth, - openPR.com
Saudia Arabia Introduces Strategic Healthcare Vision and Global Partnerships at BIO 2025 - GlobeNewswire Inc.
Next-Gen Diagnostics Drive Biochips Market Growth: Thermo Fisher, Illumina, and PerkinElmer at the Forefront - openPR.com
Illumina and Science Centre Singapore partner for Brain Fest 2025 - Illumina
Video: Inspiring the next generation of scientists in Singapore - Illumina
Clinical Oncology Next Generation Sequencing Market Detailed - openPR.com
Illumina (ILMN) Price Target Boosted by Canaccord Analyst | ILMN Stock News - GuruFocus
Video: Two Illumina scientists share their “why” - Illumina
Breaking Down Illumina: 11 Analysts Share Their Views - Benzinga
lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics - Illumina
Lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics - marketscreener.com
Piper Sandler maintains Illumina stock Overweight, $185 target By Investing.com - Investing.com UK
Long Read Sequencing Market Top Key Players Analysis - openPR.com
Gemeinsam Genomik neu denken - Illumina
Microarray Biochips Market is Booming Worldwide |Illumina,Qiagen,Eppendorf - openPR.com
Single-cell Omics Market Projected to Witness Growth with - openPR.com
Tumor-Derived Exosomes Market Set to Witness Significant - openPR.com
Hereditary Testing Market Future Business Opportunities - openPR.com
Next Generation Sequencing Market to Witness Upsurge in Growth - openPR.com
Does Illumina (ILMN) Have Good Long-Term Growth Prospects? - Insider Monkey
Nucleic Acid Isolation and Purification Market Size, Trends & - openPR.com
Illumina’s DNA Test Tech Infringes Hospital Patent, Suit Claims - Bloomberg Law News
Microbiome Sequencing Market Outlook 2025-2029 | Affordable Sequencing Instruments Expand Market Access for Smaller Labs - Yahoo
Digital Genome Market Deep Research Report on AI-Driven DNA Analysis Trends | Illumina, Thermo Fisher Scientific - openPR.com
Forensic Genomics Market Research 2025Global Trends, Opportunity, and Forecasts 2020-2030 - GlobeNewswire Inc.
Cancer Profiling Market Is Booming So Rapidly 2025-2032 - openPR.com
Hereditary Testing MarketGlobal Industry Trends, Opportunity, and Forecast, 2020-2030: Key Players Like Illumina and Myriad Genetics Leading the Charge - Yahoo Finance
Next-Gen RNA Sequencing Market | Personalized Medicine & Future - openPR.com
Gene Panel Market Projected to Witness Massive GrowthIllumina, Inc., Thermo Fisher Scientific - openPR.com
Illumina Connected Insights - Technology Networks
Illumina Inc (ILMN) Stock Price Down 3.31% on May 30 - GuruFocus
Genotyping Assay Market Deep Research Report Highlights Key AdvancementsIllumina, Thermo Fisher Scientific - openPR.com
Illumina’s PromoterAI unlocks rare disease clues in noncoding genome - statnews.com
Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? - Nasdaq
Epigenetics Market Analysis 2025-2033: Advances in DNA - openPR.com
Illumina introduces PromoterAI for rare disease diagnosis By Investing.com - Investing.com South Africa
Illumina Inc.: Tackling Global Headwinds With Strategic Market Diversification! - Smartkarma
Illumina, Inc. (ILMN) Unveils AI Breakthrough for Rare Disease Diagnosis - Insider Monkey
Illumina introduces PromoterAI for rare disease diagnosis - Investing.com Australia
Operating a speedy, high-tech NGS lab in remote Australia - Illumina
Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis - Nasdaq
Bioinformatics Market Detailed in New Research ReportThermo Fisher Scientific, Illumina - openPR.com
DNA giant Illumina spawned an ecosystem of competitors and customers - Endpoints News
Illumina widens access to cancer tests with Medicare and new CDx - Yahoo Finance
Patent Fight Breaks Out over Genetic Sequencing - Orthopedics This Week
Illumina at Bernstein Conference: Strategic Insights and Challenges - Investing.com
1.52%
0.53%
자본화:
|
볼륨(24시간):